MX2019003818A - Metodo para la sintesis de derivado de 3-fenil-2,3,4,8,9,10-hexahi dropiran [2,3-f] cromeno e isomero optico del mismo. - Google Patents

Metodo para la sintesis de derivado de 3-fenil-2,3,4,8,9,10-hexahi dropiran [2,3-f] cromeno e isomero optico del mismo.

Info

Publication number
MX2019003818A
MX2019003818A MX2019003818A MX2019003818A MX2019003818A MX 2019003818 A MX2019003818 A MX 2019003818A MX 2019003818 A MX2019003818 A MX 2019003818A MX 2019003818 A MX2019003818 A MX 2019003818A MX 2019003818 A MX2019003818 A MX 2019003818A
Authority
MX
Mexico
Prior art keywords
hexahydropyrano
phenyl
optical isomer
chromene derivative
synthesizing optical
Prior art date
Application number
MX2019003818A
Other languages
English (en)
Inventor
Wook Chung Jin
Ku Yoo Sang
Suk KANG Ku
Young Kim Jin
Geun Jo In
Ho IM Jeong
Young Kim Ji
Original Assignee
Glaceum Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaceum Inc filed Critical Glaceum Inc
Publication of MX2019003818A publication Critical patent/MX2019003818A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)

Abstract

La presente invención se refiere a un método para la síntesis de un derivado de 3-fenil-2,3,4,8,9,10-hexahidropiran[2,3-f] cromeno y un isómero óptico del mismo, y un Compuesto intermedio que se puede utilizar para el método de síntesis, y cuando se utilizan el método y el Compuesto intermedio, el derivado de 3-fenil-2,3,4,8,9,10-hexahidropiran[2,3-f] cromeno y el isómero óptico del mismo se pueden sintetizar de manera eficaz.
MX2019003818A 2016-10-04 2017-09-27 Metodo para la sintesis de derivado de 3-fenil-2,3,4,8,9,10-hexahi dropiran [2,3-f] cromeno e isomero optico del mismo. MX2019003818A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160127805 2016-10-04
PCT/KR2017/010679 WO2018066872A1 (ko) 2016-10-04 2017-09-27 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법

Publications (1)

Publication Number Publication Date
MX2019003818A true MX2019003818A (es) 2019-08-12

Family

ID=61831886

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019003818A MX2019003818A (es) 2016-10-04 2017-09-27 Metodo para la sintesis de derivado de 3-fenil-2,3,4,8,9,10-hexahi dropiran [2,3-f] cromeno e isomero optico del mismo.

Country Status (19)

Country Link
US (2) US10669282B2 (es)
EP (1) EP3524609B1 (es)
JP (1) JP6810275B2 (es)
KR (2) KR20180037584A (es)
CN (1) CN109863152B (es)
AR (1) AR109735A1 (es)
AU (1) AU2017338514B2 (es)
BR (1) BR112019006736A8 (es)
CA (1) CA3039326C (es)
DK (1) DK3524609T3 (es)
ES (1) ES2881000T3 (es)
HU (1) HUE055701T2 (es)
IL (1) IL265706B (es)
MX (1) MX2019003818A (es)
PL (1) PL3524609T3 (es)
PT (1) PT3524609T (es)
TW (1) TWI641610B (es)
WO (1) WO2018066872A1 (es)
ZA (1) ZA201902760B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2964146T3 (es) * 2016-06-29 2024-04-04 Glaceum Inc Derivado de piranocromenilfenol ópticamente activo y composición farmacéutica que lo comprende
WO2018066872A1 (ko) * 2016-10-04 2018-04-12 주식회사 글라세움 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법
TWI804600B (zh) * 2018-04-03 2023-06-11 南韓商格雷森伍股份有限公司 3-苯基-2,8-二氫吡喃[2,3-ƒ]苯并哌喃衍生物的合成方法
WO2020071818A1 (ko) * 2018-10-02 2020-04-09 주식회사 글라세움 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매
KR20200038182A (ko) * 2018-10-02 2020-04-10 주식회사 글라세움 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매
KR20200105198A (ko) * 2019-02-28 2020-09-07 주식회사 글라세움 신경계 질환의 예방 또는 치료용 약학적 조성물
KR20210014521A (ko) * 2019-07-30 2021-02-09 주식회사 글라세움 2-((6-(히드록시메틸)크로멘-5-일)옥시)-1-페닐에타논 유도체의 합성 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100565423B1 (ko) 2003-10-20 2006-03-30 빅 바이오 주식회사 이소플라반 유도체 또는 이소플라벤 유도체의 제조방법
JP2006008604A (ja) * 2004-06-25 2006-01-12 Kuraray Co Ltd イソフラバン誘導体の製造方法
KR20070052211A (ko) 2005-11-16 2007-05-21 주식회사 엠디바이오알파 글라브리딘을 유효성분으로 함유하는 질환 증후군 예방 및치료용 조성물
US8563599B2 (en) * 2008-03-03 2013-10-22 The United States Of America, Represented By The Secretary Of Agriculture Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof
CN101555259B (zh) * 2009-05-15 2012-06-27 中国科学院上海有机化学研究所 螺环骨架膦噁唑啉配体、合成方法及其在不对称氢化反应中的应用
CN103030647B (zh) * 2013-01-16 2014-10-29 山东省分析测试中心 一种光甘草定的合成方法
KR102344479B1 (ko) 2013-12-24 2021-12-29 주식회사 글라세움 피라노크로메닐페놀 유도체, 및 대사증후군 또는 염증 질환 치료용 약학 조성물
ES2964146T3 (es) * 2016-06-29 2024-04-04 Glaceum Inc Derivado de piranocromenilfenol ópticamente activo y composición farmacéutica que lo comprende
WO2018066872A1 (ko) * 2016-10-04 2018-04-12 주식회사 글라세움 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법

Also Published As

Publication number Publication date
DK3524609T3 (da) 2021-07-26
TW201813970A (zh) 2018-04-16
US20200048272A1 (en) 2020-02-13
AU2017338514A1 (en) 2019-05-23
PT3524609T (pt) 2021-07-15
AU2017338514B2 (en) 2020-05-14
ZA201902760B (en) 2021-09-29
IL265706A (en) 2019-05-30
BR112019006736A2 (es) 2019-07-23
KR20180037584A (ko) 2018-04-12
KR20180091803A (ko) 2018-08-16
IL265706B (en) 2021-06-30
EP3524609A4 (en) 2020-04-08
EP3524609B1 (en) 2021-05-26
US10669282B2 (en) 2020-06-02
KR101893393B1 (ko) 2018-08-30
BR112019006736A8 (pt) 2022-08-23
PL3524609T3 (pl) 2021-12-27
JP6810275B2 (ja) 2021-01-06
US10947250B2 (en) 2021-03-16
TWI641610B (zh) 2018-11-21
JP2019529577A (ja) 2019-10-17
HUE055701T2 (hu) 2021-12-28
WO2018066872A1 (ko) 2018-04-12
NZ753171A (en) 2021-05-28
CN109863152B (zh) 2021-12-03
US20200199142A1 (en) 2020-06-25
CA3039326A1 (en) 2018-04-12
AR109735A1 (es) 2019-01-16
ES2881000T3 (es) 2021-11-26
CA3039326C (en) 2022-09-20
EP3524609A1 (en) 2019-08-14
CN109863152A (zh) 2019-06-07

Similar Documents

Publication Publication Date Title
MX2019003818A (es) Metodo para la sintesis de derivado de 3-fenil-2,3,4,8,9,10-hexahi dropiran [2,3-f] cromeno e isomero optico del mismo.
WO2017100305A8 (en) Composition of antibody construct-agonist conjugates and methods of use thereof
EP3739476A4 (en) SPEECH SYNTHESIS PROCESS FROM MULTILINGUAL TEXT
NZ702752A (en) Methods for synthesizing amatoxin building block and amatoxins
EP3642182A4 (en) COMPOUNDS, COMPOSITIONS AND SYNTHESIS METHODS
EP3728202A4 (en) DIARYL-SUBSTITUTED 5,5-CONDENSED RING COMPOUNDS AS C5AR INHIBITORS
EP4279071A3 (en) Novel cannabinoid formulations
EP3728203A4 (en) DIARYL-SUBSTITUTED 6,5-CONDENSED RING COMPOUNDS AS C5AR INHIBITORS
SG11201909186YA (en) Triazole silane compound, method for synthesizing said compound and use thereof
WO2018217894A8 (en) FLUORINATED MARKED HALICHONDRIN DERIVATIVES AND METHODS OF SYNTHESIS THEREOF
WO2017139664A8 (en) Intermediates in the synthesis of eribulin and related methods of synthesis
MY181641A (en) Amino pyran ring derivative and composition and use thereof
EA201892515A1 (ru) Стероидные 6,7-бета-эпоксиды в качестве интермедиатов
MX2020006434A (es) Nuevos compuestos inhibidores del blanco mecanistico de rapamicina (mtor).
AU2017259872A1 (en) Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4- triazole derivatives
MX2020006436A (es) Compuestos inhibidores del blanco mecanistico de rapamicina (mtor).
WO2016029216A3 (en) Method for producing amidine derivatives
PH12017501869A1 (en) (s)-2'-vinyl-abscisic acid derivatives
WO2018075598A8 (en) SYNTHESIS OF EZH2 INHIBITORS
MX2018015269A (es) Derivados de tailanstatina a, metodos de tratamiento y metodos de sintesis de los mismos.
WO2017046816A3 (en) Process for the preparation of derivatives of benzodioxole
CA3094086A1 (en) Method for synthesizing 3-phenyl-2,8-dihydropyrano [2,3-f] chromene derivative
EP3974419A3 (en) Nebivolol synthesis method and intermediate compound thereof
EP3512831A4 (en) SYNTHESIS PROCESS FOR THE PRODUCTION OF ENANTIOMERICALLY PURE CIS-IMIDAZOLINE COMPOUNDS FOR PHARMACEUTICAL USE
WO2016100833A3 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs